Lilly(Eli) & Company

NYSE: LLY
$750.77
+$4.03 (+0.5%)
Closing price April 17, 2024
Eli Lilly and Company is a global leader in pharmaceuticals, focusing on discovering, developing, and marketing a wide range of human medications. With a rich history dating back to 1876 and headquartered in Indianapolis, Indiana, it offers treatments for diabetes, including a comprehensive lineup of insulin products, and type 2 diabetes medications like Jardiance and Trulicity. The company also has a strong presence in oncology, rheumatoid arthritis, dermatology, mental health, and more, with notable products such as Alimta for cancer and Cymbalta for depression. Eli Lilly collaborates with various industry partners to enhance its product offerings.
Wednesday's top analyst upgrades and downgrades included AbbVie, Blackstone, Boston Scientific, CarMax, Chewy, Eli Lilly, Medtronic, NetApp, Ping Identity, Shopify, Veru and Zscaler.
Thursday's top analyst upgrades and downgrades included Analog Devices, Eli Lilly, Fastenal, Global Payments, Keurig Dr Pepper, Lululemon Athletica, Merck, Occidental Petroleum, Rivian Automotive and...
A recent survey of global fund managers found that many have turned to health care for some stability in these uncertain times. These eight high-dividend-paying stocks are rated Buy at top Wall...
Thursday's top analyst upgrades and downgrades included Arista Networks, Bumble, Cisco Systems, ConocoPhillips, CrowdStrike, DXC Technology, Eli Lilly, Emerson Electric, Freeport-McMoRan,...
Given Warren Buffet's proclivity for only owning stock of companies that he understands inside and out, these 10 top health care picks with big, dependable dividends make sense now for growth and...
A few big biopharma names were on the move Tuesday morning, and analysts were taking their shot at them.
Friday afternoon's top analyst upgrades and downgrades included Baker Hughes, CSX, Eli Lilly, Netflix, Peloton, Under Armour and more.
The three major U.S. stock indexes are trading lower again in Friday's premarket session.
Tuesday's top analyst upgrades and downgrades included Broadcom, Carrier Global, Canadian Pacific Railway, Coca-Cola, Eli Lilly, Marvell Technology, Pfizer, Regions Financial, Stryker, Synchrony...
Thursday's top analyst upgrades and downgrades included AT&T, Abbott Laboratories, Advanced Micro Devices, Affirm, Canopy Growth, Cleanspark, Eli Lilly, ESS Tech, Global Payments and Luminar...
Monday's top analyst upgrades and downgrades included Adobe, Arista Networks, AT&T, Bristol-Myers Squibb, Canopy Growth, Deere, Eli Lilly, Invesco, Medtronic, Mosaic, 3M, Roblox, Starbucks, Tesla,...
Eli Lilly and these other top companies are expected to lift the dividends they pay to shareholders, and their stocks are rated Buy across Wall Street, making them excellent total return candidates.
Friday’s top analyst upgrades and downgrades included Altice USA, AppLovin, Biogen, Bristol-Myers Squibb, Broadcom, Ciena, Cloudflare, Denison Mines, Diageo, Eli Lilly, Rio Tinto and Southwest...
Monday's top analyst upgrades and downgrades included Adobe, Anheuser-Busch, Baker Hughes, Chevron, Eli Lilly, Halliburton, Home Depot, Intuit, Microsoft, Robinhood Markets, Shopify, Sirius XM,...
Monday's top analyst upgrades and downgrades included Carvana, Cloudflare, Comcast, ConocoPhillips, Constellation Brands, Exxon Mobil, Eli Lilly, SoFi Technologies and Starbucks.